FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Mefloquine HCL Tablets Recall

Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack

Teva Pharmaceuticals USA, Inc. · Sellersville, PA

Risk level
Class II
Reported by FDA
Jul 4, 2012
Recall ID
D-1396-2012
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Mefloquine HCL Tablets starting Apr 2, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1396-2012 on Jul 4, 2012. Reason: Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight. Status: Terminated.

Why it was recalled

Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.

Product description

Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78

Lot numbers, UPCs & expiration codes

Lot # 34000741A; Expiration date: 7/2013

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1396-2012
Classification
Class II
Status
Terminated
Recall initiated
Apr 2, 2012
FDA report date
Jul 4, 2012
Quantity
4188 cartons (5 X 5 blisterpacks)
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc.

Original FDA data

Every field from FDA enforcement report D-1396-2012, exactly as published.

Show all FDA fields
City
Sellersville
State
PA
Status
Terminated
Country
United States
Event ID
61664
Address
650 Cathill Rd
Code information
Lot # 34000741A; Expiration date: 7/2013
Postal code
18960-1512
Report date
Jul 4, 2012
Product type
Drugs
Recall number
D-1396-2012
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA, Inc.
Product quantity
4188 cartons (5 X 5 blisterpacks)
Termination date
Mar 22, 2013
Reason for recall
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78
Distribution pattern
Nationwide
Recall initiation date
Apr 2, 2012
Initial firm notification
Letter
Center classification date
Jun 26, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1396-2012, published Jul 4, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls